# Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo

> **NCT00744965** · PHASE4 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 395 (actual)

## Conditions studied

- Mild Gestational Diabetes

## Interventions

- **DRUG:** Glyburide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00744965
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09-16
- **Primary completion:** 2013-01
- **Final completion:** 2016-01
- **Target enrollment:** 395 (ACTUAL)
- **Last updated:** 2020-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00744965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00744965, "Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00744965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*